178
Casu B, Reggiani M, Sanderson GR (1979) Methylated cycloamyloses (cyclodextrins) and their
inclusion complexes. Carbohydr Res 76:59–66. https://doi.org/10.1016/0008-6215(79)80006-3
Casu B, Choay J, Ferro DR, Gatti G, Jacquinet JC, Petitou M, Provasoli A, Ragazzi M, Sinay P,
Torri G (1986) Controversial glycosaminoglycan conformations. Nature 322:215–216. https://
doi.org/10.1038/322215b0
Casu B, Grenni A, Naggi AM, Torri G (1988) Interactions of cyclodextrins with glycolipids.
1H-NMR studies. Proceedings of fourth International symposium cyclodextrins. In: Huber O,
Szejtli J (eds) Advances in inclusion science, vol 5. Springer, Dordrecht, pp 189–195. https://
doi.org/10.1007/978-94-009-2637-0_29
Casu B, Grenni A, Naggi AM, Torri G, Virtuani M, Focher B (1990) Interaction of cyclodextrins (cyclomalto-oligosaccharides) with glycolipids: NMR studies of aqueous systems of cyclo-maltohexaose and glycosides. Carbohydr Res 200:101–109. https://doi.
org/10.1016/0008-6215(90)84185-W
Casu B, Lanzarotti E, Torri G, Naggi A, Cedro A (1992) Purification for the isolation and purification of a monosialoganglioside from a lipid mixture by complexation with alpha-cyclodextrin
and related compound. US Patent 5,108,613
Casu B, Naggi AM, Torri G (2001) Synthesis of sulfated glycosaminoglycans. In: Fraser-Reid
BO, Tatsuta K, Thiem J (eds) Glycoscience – chemistry and chemical biology, vol 3. Springer,
Berlin, pp 1895–1904. https://doi.org/10.1007/978-3-642-56874-9_45
Casu B, Naggi A, Torri G (2015) Re-visiting the structure of heparin. Carbohydr Res 403:60–68.
https://doi.org/10.1016/j.carres.2014.06.023
Cramer F (1952) Einschluβverbindungen. Angew Chem 64:437–447
Cramer F (1954) Einschlussverbindungen. Springer, Berlin. ISBN: 978-3-642-49192-4
Cramer F, Henglein FM (1956) Einschlussverbindungen der cyclodextrine mit gasen. Angew
Chem Int Ed 68:649–649
Cramer F, Hettler H (1967) Inclusion compounds of cyclodextrins. Naturwissenschaften
54:625–632
Cramer F, Saenger W, Spatz HC (1967) Inclusion compounds. XIX. The formation of inclusion
compounds of α-cyclodextrin in aqueous solutions. Thermodynamics and kinetics. J Am Chem
Soc 89:14–20
Crini G (2014) Review: a history of cyclodextrins. Chem Rev 114:10940–10975. https://doi.
org/10.1021/cr500081p
Crini G, Torri G (2017) In memoriam Benito Casu (1927–2016). Carbohydr Res 448:227–228.
https://doi.org/10.1016/j.carres.2017.06.001
Crini G, Fourmentin S, Fenyvesi É, Torri G, Fourmentin M, Morin-Crini N (2018) Cyclodextrins,
from molecules to applications. Environ Chem Lett 16:1361–1375. https://doi.org/0.1007/
s10311-018-0763-2
Demarco PV, Thakkar AL (1970) Cyclohepta-amylose inclusion complexes. A proton magnetic
resonance study. J Chem Soc Chem Commun:2–4
Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri
S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J,
Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, Sasisekharan R (2008) Oversulfated
chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat
Biotechnol 26:669–675. https://doi.org/10.1038/nbt1407
Guerrini M, Shriver Z, Bisio A, Naggi AM, Casu B, Sasisekharan R, Torri G (2009) The tainted heparin story: an update. Thromb Haemost 102:907–911. https://doi.org/10.1160/TH09-02-0079
Guerrini M, Shriver Z, Naggi A, Casu B, Linhardt RJ, Torri G, Sasisekharan R (2010) Oversulfated
chondroitin sulfate is not the sole contaminant in heparin. Nat Biotechnol 28:207–211
Harenberg J, Casu B (2009) Heparin and its derivatives – present and future. Thromb Haemost
102:801–803. https://doi.org/10.1160/TH09-10-0698
Higuchi T, Connors KA (1965) Phase solubility techniques. Adv Anal Chem Instrum 4:117–212
G. Torri et al.
Casu B, Reggiani M, Sanderson GR (1979) Methylated cycloamyloses (cyclodextrins) and their
inclusion complexes. Carbohydr Res 76:59–66. https://doi.org/10.1016/0008-6215(79)80006-3
Casu B, Choay J, Ferro DR, Gatti G, Jacquinet JC, Petitou M, Provasoli A, Ragazzi M, Sinay P,
Torri G (1986) Controversial glycosaminoglycan conformations. Nature 322:215–216. https://
doi.org/10.1038/322215b0
Casu B, Grenni A, Naggi AM, Torri G (1988) Interactions of cyclodextrins with glycolipids.
1H-NMR studies. Proceedings of fourth International symposium cyclodextrins. In: Huber O,
Szejtli J (eds) Advances in inclusion science, vol 5. Springer, Dordrecht, pp 189–195. https://
doi.org/10.1007/978-94-009-2637-0_29
Casu B, Grenni A, Naggi AM, Torri G, Virtuani M, Focher B (1990) Interaction of cyclodextrins (cyclomalto-oligosaccharides) with glycolipids: NMR studies of aqueous systems of cyclo-maltohexaose and glycosides. Carbohydr Res 200:101–109. https://doi.
org/10.1016/0008-6215(90)84185-W
Casu B, Lanzarotti E, Torri G, Naggi A, Cedro A (1992) Purification for the isolation and purification of a monosialoganglioside from a lipid mixture by complexation with alpha-cyclodextrin
and related compound. US Patent 5,108,613
Casu B, Naggi AM, Torri G (2001) Synthesis of sulfated glycosaminoglycans. In: Fraser-Reid
BO, Tatsuta K, Thiem J (eds) Glycoscience – chemistry and chemical biology, vol 3. Springer,
Berlin, pp 1895–1904. https://doi.org/10.1007/978-3-642-56874-9_45
Casu B, Naggi A, Torri G (2015) Re-visiting the structure of heparin. Carbohydr Res 403:60–68.
https://doi.org/10.1016/j.carres.2014.06.023
Cramer F (1952) Einschluβverbindungen. Angew Chem 64:437–447
Cramer F (1954) Einschlussverbindungen. Springer, Berlin. ISBN: 978-3-642-49192-4
Cramer F, Henglein FM (1956) Einschlussverbindungen der cyclodextrine mit gasen. Angew
Chem Int Ed 68:649–649
Cramer F, Hettler H (1967) Inclusion compounds of cyclodextrins. Naturwissenschaften
54:625–632
Cramer F, Saenger W, Spatz HC (1967) Inclusion compounds. XIX. The formation of inclusion
compounds of α-cyclodextrin in aqueous solutions. Thermodynamics and kinetics. J Am Chem
Soc 89:14–20
Crini G (2014) Review: a history of cyclodextrins. Chem Rev 114:10940–10975. https://doi.
org/10.1021/cr500081p
Crini G, Torri G (2017) In memoriam Benito Casu (1927–2016). Carbohydr Res 448:227–228.
https://doi.org/10.1016/j.carres.2017.06.001
Crini G, Fourmentin S, Fenyvesi É, Torri G, Fourmentin M, Morin-Crini N (2018) Cyclodextrins,
from molecules to applications. Environ Chem Lett 16:1361–1375. https://doi.org/0.1007/
s10311-018-0763-2
Demarco PV, Thakkar AL (1970) Cyclohepta-amylose inclusion complexes. A proton magnetic
resonance study. J Chem Soc Chem Commun:2–4
Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri
S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J,
Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, Sasisekharan R (2008) Oversulfated
chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat
Biotechnol 26:669–675. https://doi.org/10.1038/nbt1407
Guerrini M, Shriver Z, Bisio A, Naggi AM, Casu B, Sasisekharan R, Torri G (2009) The tainted heparin story: an update. Thromb Haemost 102:907–911. https://doi.org/10.1160/TH09-02-0079
Guerrini M, Shriver Z, Naggi A, Casu B, Linhardt RJ, Torri G, Sasisekharan R (2010) Oversulfated
chondroitin sulfate is not the sole contaminant in heparin. Nat Biotechnol 28:207–211
Harenberg J, Casu B (2009) Heparin and its derivatives – present and future. Thromb Haemost
102:801–803. https://doi.org/10.1160/TH09-10-0698
Higuchi T, Connors KA (1965) Phase solubility techniques. Adv Anal Chem Instrum 4:117–212
G. Torri et al.